In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic. - Wikidata - wikimedia - TriplyDB

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

http://www.wikidata.org/entity/Q37392858

about

Genetic basis of high level aminoglycoside resistance in Acinetobacter baumannii from Beijing, China.Amikacin: Uses, Resistance, and Prospects for Inhibition.

P2860

Q36237535-B8C0330B-88C2-427D-9460-1E16FA4189C8 Q52744431-8102E2E4-CD9A-4434-A0E6-56FC6BFD7923

P2860

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

http://www.wikidata.org/entity/Q37392858

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@en

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@nl

type

label

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@en

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@nl

prefLabel

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@en

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@nl

P1433

Q37392858-A1DF94B0-FAA7-4CBB-8C90-FE5563B0AE22

P1476

Q37392858-CE97B89D-F11D-46B7-B73A-F8F7CAAF9884

P2093

Q37392858-11B45794-0411-4371-84AB-9A0D44E8982D

Q37392858-50CCD758-9BE7-4829-BC73-1ECD8CFA1C70

Q37392858-614102EC-C48A-4140-820B-EEBD804284E9

Q37392858-6196B69D-5B0F-43A2-A3B6-CAAB5EBB54DB

Q37392858-6660317B-C3CF-4A67-A37E-0A134B75EA5C

Q37392858-6E73D604-7C4E-4E2B-838A-436061B89420

Q37392858-6F0F6BB8-1EFA-4B95-95D8-A6CC3B782E37

Q37392858-8291D7BC-7B22-4AE4-A419-885E8972F024

Q37392858-A7527BE2-030F-433E-9746-12EAE5B5AD9E

Q37392858-B8FEDD66-0331-41AE-A883-E63CC62221A9

P2860

Q37392858-1F20385F-B993-4159-A4DB-3E7D288A3CED

Q37392858-2CCB6CBF-0BE9-48A3-935B-BBDDE120CACB

Q37392858-4B9640F4-7A41-435D-96CC-7BCFA2F14160

Q37392858-4E3C56DF-0977-4ACE-8A9B-315FA3E64ECB

Q37392858-62D37E75-39D4-4DD7-B3BE-9B67DEA6BBFB

Q37392858-794E71E9-9468-4E1A-A9DE-2AF365C326B2

Q37392858-98C4FC11-6193-45D0-8F17-C22A508042F1

Q37392858-AB4026B3-2D05-4FBE-BD84-D71E2635C3DD

Q37392858-C9A86940-5993-4FB1-9BA3-AF53151DAABB

Q37392858-DEAE0883-A58E-4CAA-A736-436702CB8C62

P304

Q37392858-89689CA2-8328-4070-B84A-13150772D04D

P31

Q37392858-936EEA1B-1BAF-445F-AD65-A7310C297C41

P356

Q37392858-7B98ADE9-5D3E-498C-937C-F943DA813C90

P407

Q37392858-968973F1-16B9-48FC-BE98-906027BFB19C

P433

Q37392858-A4F931F8-2713-4AF5-BD2A-0FB8FE7D4617

P478

Q37392858-4DA0B134-3C87-49B1-86EA-A024B8490A90

P577

Q37392858-844C862A-A421-4D26-99A2-E1385590DD74

P698

Q37392858-0304966B-613C-463C-84A9-0B97C4D37E1B

P932

Q37392858-FAFF95FF-DB5F-48F3-BB16-5C2F0681E17F

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

In vivo antibacterial activity of vertilmicin, a new aminoglycoside antibiotic.

@en

P2093

Cheng-Hang Sun

http://www.w3.org/2001/XMLSchema#string

Cong-Ran Li

http://www.w3.org/2001/XMLSchema#string

Dan-Qing Song

http://www.w3.org/2001/XMLSchema#string

Guo-Qing Li

http://www.w3.org/2001/XMLSchema#string

Hui-Zhen Chen

http://www.w3.org/2001/XMLSchema#string

Jian-Dong Jiang

http://www.w3.org/2001/XMLSchema#string

Li-Xun Zhao

http://www.w3.org/2001/XMLSchema#string

Li-Yan Yu

http://www.w3.org/2001/XMLSchema#string

Min Yuan

http://www.w3.org/2001/XMLSchema#string

Ren-Hui Lou

http://www.w3.org/2001/XMLSchema#string

P2860

Aminoglycosides: activity and resistance.

Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.

In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models.

In vitro antibacterial activity of vertilmicin and its susceptibility to modifications by the recombinant AAC6'-APH2'' enzyme.

Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.

Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031.

Standardized burn model using a multiparametric histologic analysis of burn depth.

Bacterial resistance to aminoglycoside antibiotics.

Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis.

P304

4525-4528

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00223-09

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19635958

http://www.w3.org/2001/XMLSchema#string

P932

2764209

http://www.w3.org/2001/XMLSchema#string